Cite
HARVARD Citation
Verzeroli, C. et al. (n.d.). Hemostatic biomarkers levels for the identification of cancer patients at higher VTE risk enrolled in the HYPERCAN study. Thrombosis research. pp. S198-S199. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Verzeroli, C. et al. (n.d.). Hemostatic biomarkers levels for the identification of cancer patients at higher VTE risk enrolled in the HYPERCAN study. Thrombosis research. pp. S198-S199. [Online].